Skip to the main content.
Login Contact us
2022.01.27 Breast AI Diamond
Breast AI Logo

by Arterys®


AI gets real.
The World-Class Solution for Early Detection of Breast Cancer.

Breast AI provides cloud-native AI solutions for breast cancer detection, breast density measurement, and personalized risk assessment that offer clinically proven benefits to clinicians and patients, and are designed to optimize efficiency, enhance the patient experience, and improve outcomes.

Breast AI Hero Image

Superior Accuracy


Improve breast cancer detection1 and accurately identify women at high risk of developing breast cancer in the short term2,3

Increase Efficiency


Reduce reading time by as much as 52.7%1 with automated detection and analysis of DTB images which assists in prioritizing caseloads and clinical decision-making

Optimized Workflow


Anytime, anywhere, access to results through a single user interface zero-footprint viewer and an internet connection - No on-premises hardware required

Consistent Results


Simplify and standardize breast density stratification and reporting with accurate and reliable results

Breast Cancer Detection


Breast AI offers a high-performing, concurrent read cancer detection and workflow solution that rapidly and accurately analyzes each DBT image detecting both malignant soft tissue densities and calcifications with unrivaled accuracy.1,4,5,6,7

This innovative solution provides radiologists with key information, such as Certainty of Finding lesion and Case Scores, which assists in prioritizing caseloads, clinical decision-making and may help to reduce physician burnout.

Get access to clinically proven benefits, including an 8% improvement in sensitivity, a 7% improvement in specificity, and a 52.7% reduction in reading time for radiologists.1

Breast AI Detection Comparison Charts-1

Density Assessment


Breast AI leverages a deep learning algorithm for accurate automated breast density assessments on the Arterys platform. This solution simplifies and standardizes breast density stratification and reporting with accurate and reliable results.4,8

Using mammographic images, the algorithm analyzes the woman’s breast anatomy and categorizes her breast density within the appropriate BI-RADS® 5th edition density category.

Breast AI density assessment image webpage

Personalized Risk Assessment


Breast AI offers a clinical decision support tool that provides an accurate, personalized short-term breast cancer risk estimation for each woman.

This easy-to-implement solution uniquely combines a range of risk factors, offering superior performance in assessing short-term risk compared to traditional breast cancer risk models.2,3,4  Specifically designed to factor in racial and ethnic backgrounds, this solution offers an equitable and inclusive approach to precision screening.4

The algorithm also factors in clinically relevant global screening guidelines and more than 15 country incidence and mortality reference tables for alignment with that country’s general population.

Breast AI Personalized Breast Screening Risk Larger Image - On webpage

Learn more about Breast AI

Speak with an Arterys expert about how Breast AI can help your team achieve fast, consistent results within your current workflow.

Schedule a Demo

More Breast AI information from the Arterys Blog

Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution

Arterys, a Tempus company, has announced a US and EU distribution agreement with Therapixel, a medical imaging software...

Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

The 2023 Society of Breast Imaging (SBI) Breast Imaging Symposium is a must-attend event for radiologists and...

Arterys Grows Partnerships Including Amazon HealthLake Imaging

Arterys is proud to announce further adoption, growth, and partnerships, including a lineup with Amazon HealthLake...

Arterys has joined Tempus, and we are excited to reintroduce ourselves to you as Tempus Radiology.
Tempus is a leading technology company that is advancing precision medicine through the practical application of data and artificial intelligence in healthcare. By joining forces, Arterys’ product will be integrated into Tempus’ solutions, enabling providers to access a comprehensive patient view (now inclusive of radiology scans) and researchers to leverage this new data modality to optimize the drug development process.